Chapter four sheds lights on enzymes, which represents a large class of targets of small-molecules.

Michaelis-Menten kinetics

This part is covered well by biochemical introductory texts. It is essential to fully understand (one form of) the Michaelis-Menten equation:

V=Vmax×[S]Km+[S]

where V represents velocity of the reaction, [S] represents the concentration of the substrate, and Km represents the Michaelis-Menten constant, which equals the substrate concentration at which V reaches half of Vmax, which represents half of the theoretically maximum velocity of the reaction.

Once this equation is understood, its linear transformation, the Lineweaver-Burk equation, is easy to understand:

1V=KmVmax×1[S]+1Vmax

Enzynmic inhibitors

Drug-mediated enzymic inhibition is mostly reversible. We differentiate between three types of reversible inhibition:

  • Competitive inhibition
  • Noncompetitive inhibition
  • Uncompetitive inhibition

Competitive inhibition

The inhibitor binds to the active site of the enzyme in competitive inhibition. In competitive inhibition, Vmax is unchanged but Km increases.

Noncompetitive inhibition

The inhibitor binds to an allosteric site, namely a site other from the active site which nevertheless has a regulatory role of the enyzmic function. Note that in noncompetitive inhibition, the inhibitor can bind both the enzyme and the enzyme-substrate complex. This can modulate the enzymic conversion from the substrate to the product.

In noncompetitive inhibition, as the inhibitor’s concentration increases, Vmax decreases. At the same time, however, Km remains constant, because a noncompetitive inhibitor does not affect the affinity of the enzyme for the substrate - it just reduces what Vmax maximally can be.

Uncompetitive inhibition

An uncompetitive inhibitor binds only to the enzymic-substrate complex, which reudces both Vmax and Km.

A short summary of reversible inhibitors

E stands for enzyme, ES stands for enzyme-substrate complex.

Type Binding target Vmax Km
Competitive inhibitor Active site of E Unchanged Increased
Noncompetitive inhibitor Allosteric site of E Decreased Unchanged
Uncompetitive inhibitor ES Decreased Decreased

Irreversible inhibitors

Irreversible inhibitors will chemically react with the enzyme and covalently bind to it. Off-target effects of such inhibitors may cause side effects and other problems. However, recently attentions have also been paid to such inhibitors, especially in certain settings such as oncology and infectious disease. For instance, suicide inhibition happens when the enzyme converts the inhibitor into a reactive form in its active site.

Enzymic inhibition

Two types of measures were introduced: IC50 and Ki.

IC50

IC50 is the concentration at which the reaction velocity is at half of Vmax.

Ki

Ki is a constant that is independent of how the experiment is performed. It can be determined by the following equation.

Kmobs=KmKi[I]+Km

where [I] represents the inhibitor’s concentration, and Kmobs is the observed Km that is modulated by the inhibitor.

One apparent advantage of using Ki over using IC50 is that while IC50 depends on the concentration of substrate, Ki remains constant irrespective of the substrate’s concentration. Therefore Ki is sometimes perceived as a more rigorous measurement of enzyme inhibition.

Cheng-Prussoff equation

Ki and IC50 can be converted to each other by the Cheng-Prussoff equation:

Ki=IC501+[S]Km

It is obvious that Ki is positively correlated with IC50 when [S] and Km is fixed. Therefore lower Ki values, similar with lower IC50 values, are associated with more potent compounds.

Further notes on Ki and IC50

Often Ki is reported as pKi (logKi), and similarly IC50 as pIC50 (logIC50).

Only Ki values can be directly compared between each other; two IC50 values should not be directly compared unless they are obtained under identical experimental conditions.